- Your selection
- Clear all
- Pharmaceuticals x
- Global x
1 case(s) found.
In 2012, GlaxoSmithKline negotiated the largest health-fraud settlement to date with the U.S. Government over allegations of off-label marketing, bribing doctors, and failure to report drug safety problems. As well as the $3 billion settlement, GSK signed a five-year Corporate Integrity Agreement, which included corrective measures in sales and marketing practices.
-
Reference 6024
-
Published 29 Jun 2015
-
Length 6 page(s)
-
Topic Responsibility
-
Region Global
-
Industry Pharmaceuticals
In 2012, GlaxoSmithKline negotiated the largest health-fraud settlement to date with the U.S. Government over allegations of off-label marketing, bribing doctors, and failure to report drug safety problems. As well as the $3 billion settlement, GSK signed a five-year Corporate Integrity Agreement, which included corrective measures in sales and marketing practices.